Peanut Butter for Prediabetes

SM
KP
Overseen ByKristina Petersen, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Penn State University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The purpose of this study is to look at the effect of consuming peanut butter at breakfast on blood sugar control, cognitive function, and heart disease risk factors in middle-aged adults with prediabetes.

Are You a Good Fit for This Trial?

This trial is for middle-aged adults who have prediabetes. People with other serious health conditions or allergies to peanuts likely cannot participate.

Inclusion Criteria

I have a smartphone or am willing to use one for the study.
I am between 40 and 65 years old.
BMI 25 to 40 kg/m2
See 2 more

Exclusion Criteria

Hemoglobin <13.2 g/dL for men or <11.7 g/dL for women at screening
LDL-cholesterol ≥190 mg/dL assessed by the Martin-Hopkins equation at screening
Fasting triglycerides >350 mg/dL at screening
See 26 more

What Are the Treatments Tested in This Trial?

Trial Overview

The study compares the effects of eating peanut butter at breakfast versus following a usual diet, focusing on blood sugar control, thinking skills, and heart disease risk factors.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: Peanut Butter-Usual DietExperimental Treatment2 Interventions
Group II: Usual Diet-Peanut ButterActive Control2 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

Penn State University

Lead Sponsor

Trials
380
Recruited
131,000+